West Pharmaceutical Dividends
| WST Stock | USD 245.38 1.16 0.47% |
At this time, West Pharmaceutical's Dividends Paid is comparatively stable compared to the past year. Dividend Paid And Capex Coverage Ratio is likely to gain to 2.28 in 2026, whereas Dividend Yield is likely to drop 0 in 2026. West Pharmaceutical's past performance could be the main factor of why investors trade West Pharmaceutical Services stock today. Investors should clearly understand every aspect of the West Pharmaceutical dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest West Pharmaceutical's dividend schedule and payout information. West Pharmaceutical Services dividends can also provide a clue to the current valuation of West Pharmaceutical.
Number Of Dividends | Years Issued 42 | Previous Year 4 Times | Current Year 2 Times | Year Average 3.98 | Volatility 0.35 |
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 61.2 M | 64.3 M | |
| Dividend Payout Ratio | 0.12 | 0.12 | |
| Dividend Paid And Capex Coverage Ratio | 2.17 | 2.28 |
Investing in dividend-paying stocks, such as West Pharmaceutical Services is one of the few strategies that are good for long-term investment. Ex-dividend dates are significant because investors in West Pharmaceutical must own a stock before its ex-dividend date to receive its next dividend.
West Pharmaceutical Dividends Paid Over Time
Today, most investors in West Pharmaceutical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various West Pharmaceutical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of West Pharmaceutical dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
West Pharmaceutical Historical Dividend Yield Growth
A solid dividend growth pattern of West Pharmaceutical could indicate future dividend growth is likely, which can signal long-term profitability for West Pharmaceutical Services. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is West Pharmaceutical Services dividend as a percentage of West Pharmaceutical stock price. West Pharmaceutical dividend yield is a measure of West Pharmaceutical stock productivity, which can be interpreted as interest rate earned on an West Pharmaceutical investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Recent West Pharmaceutical Dividends Paid (per share)
Dividends Paid |
| Timeline |
West Pharmaceutical Expected Dividend Income Per Share
Dividend payment represents part of West Pharmaceutical's profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in West Pharmaceutical. West Pharmaceutical's board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$0.69 |
One Year
West Pharmaceutical Services expected dividend income per share adjusted for ongoing price standard deviation
West Pharmaceutical Past Distributions to stockholders
| 4th of February 2026 | ||
| 19th of November 2025 | ||
| 6th of August 2025 | ||
| 7th of May 2025 | ||
| 11th of February 2025 | ||
| 7th of February 2025 | ||
| 20th of November 2024 | ||
| 7th of August 2024 | ||
| 15th of May 2024 | ||
| 1st of May 2024 |
Is there potential for Health Care Equipment & Supplies market expansion? Will West introduce new products? Factors like these will boost the valuation of West Pharmaceutical. Anticipated expansion of West directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about West Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.021 | Dividend Share 0.85 | Earnings Share 6.79 | Revenue Per Share | Quarterly Revenue Growth 0.075 |
Investors evaluate West Pharmaceutical using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating West Pharmaceutical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause West Pharmaceutical's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between West Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if West Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, West Pharmaceutical's market price signifies the transaction level at which participants voluntarily complete trades.